Drug Profile
Research programme: venom-derived molecules - Cytopia/Xenome
Alternative Names: Venom-derived molecules research programme - Cytopia/XenomeLatest Information Update: 30 Sep 2004
Price :
$50
*
At a glance
- Originator Cytopia Research; Xenome
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Inflammation
Most Recent Events
- 30 Sep 2004 Cytopia and Xenome have completed their collaboration
- 17 Oct 2002 Preclinical trials in Cancer in Australia (unspecified route)
- 17 Oct 2002 Preclinical trials in Inflammation in Australia (unspecified route)